Extended-spectrum-β-lactamase-producing Escherichia coli isolate possessing the shiga toxin gene (stx1) belonging to the O64 serogroup associated with human disease in India

Journal of Clinical Microbiology

Volumn 51, Issue 6, 2013, Pages 2008-2009

  Dutta, T K ^a   Warjri, Iadarilin ^a   Roychoudhury, P ^a   Lalzampuia, H ^a   Samanta, I ^b   Joardar, S N ^b   Bandyopadhyay, S ^c   Chandra, Rajesh ^a  

^a CENTRAL AGRICULTURAL UNIVERSITY   (India)

^b WEST BENGAL UNIVERSITY OF ANIMAL AND FISHERY SCIENCES   (India)

^c INDIAN VETERINARY RESEARCH INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE SHV; CEFOTAXIME; CEFTRIAXONE; VEROTOXIN 1;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BLA CTX M 1 GENE; BLA SHV GENE; CONSENSUS SEQUENCE; DIARRHEA; ENTEROPATHOGENIC ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; FECES CULTURE; HUMAN; IN VITRO STUDY; INDIA; LETTER; MAJOR CLINICAL STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROTYPE; SHIGA TOXIN 1 GENE; SHIGA TOXIN PRODUCING ESCHERICHIA COLI;

BETA-LACTAMASES; ESCHERICHIA COLI INFECTIONS; HUMANS; INDIA; O ANTIGENS; SEROTYPING; SHIGA TOXIN 1; SHIGA-TOXIGENIC ESCHERICHIA COLI;

ESCHERICHIA COLI;

EID: 84878507006     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00575-13     Document Type: Letter

References (26)

1. O157. J. Clin. Microbiol. 36:598-602.
2. King LA, Mailles A, Mariani-Kurkdjian P, Vernozy-Rozand C, Montet MP, Grimont F, Pihier N, Devalk H, Perret F, Bingen E, Espié E, Vaillant V. 2009. Community-wide outbreak of Escherichia coli O157:H7 associated with consumption of frozen beef burgers. Epidemiol. Infect. 137:889-896.
3. Dhanashree B, Mallya PS. 2008. Detection of Shiga-toxigenic Escherichia coli (STEC) in diarrhoeagenic stool & meat samples in Mangalore, India. Indian J. Med. Res. 128:271-277.
4. Valat C, Auvray F, Forest K, Metayer V, Gay E, Garam CPD, Madec JY, Haenni M. 2012. Phylogenetic grouping and virulence potential of extended spectrum β-lactamase producing Escherichia coli strains in cattle. Appl. Environ. Microbiol. 78:4677-4682.
5. 1)-positive Escherichia coli O26:H11: a new concern. J. Clin. Microbiol. 43:1072-1075.
6. Valat C, Haenni M, Saras E, Auvray F, Forest K, Oswald E, Madec JY. 2012. CTX-M-15 extended-spectrum β-lactamase in a Shiga toxin-producing Escherichia coli isolate of serotype O111:H8. Appl. Environ. Microbiol. 78:1308-1309.
7. Buvens G, Bogaerts P, Glupczynski Y, Lauwers S, Pierad D. 2010. Antimicrobial resistance testing of verocytotoxin-producing Escherichia coli and first description of TEM-52 extended spectrum β-lactamase in serogroup O26. Antimicrob. Agents Chemother. 54:4907-4909.
8. Kon M, Kurazono T, Ohshima M, Yamaguchi M, Morita K, Watanabe N, Kanamori M, Matsushita S. 2005. Cefotaxime-resistant Shiga toxin-producing Escherichia coli O26:H11 isolated from a patient with diarrhea. Kansenshogaku Zasshi 79:161-168. (In Japanese.)
9. Roest HI, Leibana E, Wannet W, Duynhoven YV, Veldman KT, Mevius DJ. 2007. Antibiotic resistance in Escherichia coli O157 isolated between 1998 and 2003 in the Netherlands. Tijdschr. Diergeneeskd. 132:954-958. (Pubitemid 350304442)
10. Torpdahl M, Nielsen EM, Scheutz F, Olesen B, Hansen DS, Hasman H. 6 January 2013. Detection of a Shiga toxin- and extended-spectrum-β- lactamase-producing Escherichia coli O157:H7 human clinical isolate. J. Antimicrob. Chemother. [Epub ahead of print]. doi:10.1093/jac/dks516.
11. CLSI. 2011. Performance standards for antimicrobial susceptibility testing, 21st international supplement. CLSI document M100-S21. Clinical and Laboratory Standards Institute, Wayne, PA.
12. Schmitt J, Jacobs E, Schmidt H. 2007. Molecular characterization of extended-spectrum β-lactamases in Enterobacteriaceae from patients of two hospitals in Saxony, Germany. J. Med. Microbiol. 56:241-249.
13. Sun Y, Zeng Z, Chen S, Ma J, He L, Liu Y, Deng Y, Lei T, Zhao J, Liu JH. 2010. High prevalence of CTX-M extended spectrum β-lactamase genes in Escherichia coli isolates from pets and emergence of CTX-M-64 in China. Clin. Microbiol. Infect. 16:1475-1481.
14. Gniadkowski M. 2001. Evolution and epidemiology of extended spectrum β-lactamases (ESBLs) and ESBL-producing microorganisms. Clin. Microbiol. Infect. 7:597-608. (Pubitemid 34960356)
15. Versalovic J, Koeuth T, Lupski JR. 1991. Distribution of repetitive DNA sequences in eubacteria and application of fingerprinting of bacterial genomes. Nucleic Acids Res. 19:6823-6831. (Pubitemid 21913121)
16. Dabo SM, Confer AW, Sy LU. 2000. Single primer polymerase chain reaction fingerprinting for Pasteurella multocida strains from laboratory rabbits. Am. J. Vet. Res. 61:305-309.
17. Carattoli A, García-Fernández A, Varesi P, Fortini D, Gerardi S, Penni A, Mancini C, Giordano A. 2008. Molecular epidemiology of Escherichia coli producing extended-spectrum beta-lactamases isolated in Rome, Italy. J. Clin. Microbiol. 46:103-108.
18. Jain A, Roy I, Gupta MK, Kumar M, Agarwal SK. 2003. Prevalence of extended spectrum beta-lactamase producing Gram negative bacteria in septicaemic neonates in a tertiary care hospital. J. Med. Microbiol. 52:421-425. (Pubitemid 36589169)
19. Bhattacharjee A, Sen MR, Prakash P, Gaur A, Anupurba S. 2008. Increased prevalence of extended-spectrum β lactamase producers in neonatal septicaemic cases at a tertiary referral hospital. Indian J. Med. Microbiol. 26:356-360.
20. Basavaraj MC, Jyothi P, Peerapur BV. 2011. The prevalence of ESBL among Enterobacteriaceae in a tertiary care hospital of North Karnataka, India. J. Clin. Diagn. Res. 5:470-475.
21. Ensor VM, Shahid M, Evans JT, Hawkey PM. 2006. Occurrence, prevalence and genetic environment of CTX-M beta lactamases in Enterobacteriaceae from Indian hospitals. J. Antimicrob. Chemother. 58:1260-1263. (Pubitemid 44884149)
22. Jones CH, Tuckman M, Keeney D, Ruzin A, Bradford PA. 2009. Characterization and sequence analysis of extended-spectrum beta-lactamase encoding genes from Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates collected during tigecycline phase 3 clinical trials. Antimicrob. Agents Chemother. 53:465-475.
23. Lin Y, Lu M, Hui-Ling TH, Liu H, Chen C, Liu K, Lin C, Chiou C, Chiang M, Chen C, Yi-Chyi LY. 2011. Assessment of hypermucoviscosity as a virulence factor for experimental Klebsiella pneumoniae infections: comparative virulence analysis with hypermucoviscosity-negative strain. BMC Microbiol. 11:50. doi:10.1186/1471-2180-11-50.
24. Barguigua A, Fatima EO, Mustapha T, Fatna B, Fatima H, Khalid Z, Mohammed T. 2011. Characterization of ESBL-producing Escherichia coli and Klebsiella pneumoniae isolates from community in Morocco. J. Med. Microbiol. 60:1344-1352.
25. Nuesch-Inderbinen M, Hachler H, Kayser FH. 1996. Detection of genes coding for extended-spectrum SHV beta-lactamases in clinical isolates by a molecular genetic method, and comparison with the E test. Eur. J. Clin. Microbiol. Infect. Dis. 15:398-402. (Pubitemid 26181640)
26. Mellmann A, Harmsen D, Cummings CA, Zentz EB, Leopold SR, Rico A, Prior K, Szczepanowski R, Ji Y, Zhang W, McLaughlin SF, Henkhaus JK, Leopold B, Bielaszewska M, Prager R, Brzoska PM, Moore RL, Guenther S, Rothberg JM, Karch H. 2011. Prospective genomic characterization of the German enterohemorrhagic Escherichia coli O104:H4 outbreak by rapid next generation sequencing technology. PLoS One 6:e22751. doi:10.1371/journal.pone.0022751.